HomeNewsIndiaFrom 'GoCoronaGo' to 'Sampark-o-Meter': IISc, IITs develop mobile apps to aid fight against COVID-19

From 'GoCoronaGo' to 'Sampark-o-Meter': IISc, IITs develop mobile apps to aid fight against COVID-19

According to Union Health Ministry, the death toll due to the novel coronavirus rose to 166 and the number of cases to 5,734 in the country on Thursday.

April 11, 2020 / 12:37 IST
Story continues below Advertisement

From "GoCoronaGo" to "Sampark-o-Meter", the Indian Institute of Science (IISc), Bangalore and four Indian Institutes of Technology (IITs) have developed several mobile applications to aid the fight against coronavirus in the country.

The app "GoCoronaGo" has been developed by a team at IISc which can help identify people who may have crossed paths with COVID-19 suspects.

Story continues below Advertisement

"The app will help identify people who may have crossed paths with COVID-19 positive individuals or suspects by tracking their interactions in the past using bluetooth and GPS. It uses temporal network analytics in the backend to understand the risk propensity even for distant contacts, understand disease spread and identify high-risk people who are likely to contract and spread the virus," Tarun Rambha, a faculty member at IISc, told PTI.

"It also provides alerts on isolation and proximity scores, and helps enhance social distancing. It also has a geo-fencing feature for those who are under quarantine, and has the ability to provide their symptoms which is used in the risk evaluation," Rambha added.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show